Dr. Chad Larson provides GLP-1 therapy for Del Mar residents through a medically guided metabolic health program focused on steady, long-term progress. He incorporates GLP-1 medications into a structured treatment plan designed to support appetite regulation, glucose balance, and more stable energy.
Dr. Chad Larson bases treatment decisions on measurable metabolic function and objective clinical markers rather than assumptions. From his Solana Beach practice, he serves Del Mar residents seeking a personalized metabolic health program designed to support steady, long-term progress.
GLP-1 therapy uses medications that mimic hormones involved in appetite regulation, glucose control, and digestion. Dr. Chad Larson incorporates these treatments into a broader metabolic health plan rather than relying on restrictive measures alone. His goal is to address factors that may be making progress more difficult and help your treatment align with how your body responds.
Effective GLP-1 therapy in Del Mar, CA starts with restoring healthy glucose metabolism. When your cells respond properly to insulin, your body shifts away from fat storage and begins using stored energy more efficiently. Many patients notice fewer energy crashes, reduced cravings, and more consistent focus throughout the day.
GLP-1 therapy supports this shift by improving insulin signaling and stabilizing glucose response, helping metabolic systems function more predictably and efficiently over time.
GLP-1 peptides slow gastric emptying and modulate satiety signaling between the gut and brain. This physiologic shift improves the timing and strength of hunger and fullness cues, allowing appetite regulation to function more predictably.
GLP-1 therapy also influences central appetite signaling, reducing erratic hunger cues and improving cognitive regulation around eating. This supports more stable decision-making throughout the day without constant fluctuations in hunger signaling.
Peptide therapy requires careful clinical oversight. Before recommending GLP-1 therapy, Dr. Chad Larson evaluates your health history, lab results, and individual needs. He then monitors your response and adjusts the protocol as needed to support tolerability, safety, and consistent progress.
Dr. Chad Larson’s GLP-1 therapy program for Del Mar patients provides a more personalized alternative to direct-to-consumer models that may offer limited clinical evaluation. Because metabolic health involves several interconnected systems, he uses testing, careful dosing, and ongoing monitoring to guide treatment. The goal is to support steadier energy, improved balance, and more consistent progress so you can stay active and enjoy your daily routine with fewer metabolic concerns getting in the way.
We follow a structured, physician-led process that removes uncertainty and keeps your safety and outcomes at the center of every decision. Each phase is informed by objective testing and ongoing evaluation, allowing your treatment to progress with clarity, purpose, and consistency.
Your GLP-1 therapy begins with a focused, in-depth consultation that reviews your health history, current challenges, and goals. This conversation identifies why prior weight management efforts stalled and determines whether GLP-1 peptide therapy fits your metabolic profile.
During this appointment, we focus on:
Following your consultation, we order targeted laboratory testing to objectively measure key metabolic systems. These labs establish a clinical baseline and confirm how your body is functioning at a physiologic level.
Our laboratory analysis includes:
This testing detects patterns such as insulin resistance, thyroid signaling disruption, or inflammatory stress and establishes the objective data used to design your treatment. Lab results also screen for safety parameters and rule out contraindications before therapy begins.
Using your laboratory findings and clinical response, we design a case-specific GLP-1 peptide protocol aligned with your metabolism and daily life. This is where measured data is interpreted and translated into a clear treatment strategy.
Your personalized plan includes:
This approach ensures treatment decisions remain clinically aligned, responsive, and grounded in measured physiology rather than assumptions.
Dr. Chad Larson remains actively involved throughout your program, monitoring your response and adjusting your treatment as you progress. His care continues beyond the initial prescription, with ongoing guidance designed to support safe, consistent progress.
Ongoing support includes::
Dr. Chad Larson offers GLP-1 medications selected according to your clinical findings, treatment goals, and individual tolerance. He closely monitors your progress and adjusts treatment as needed to support its benefits while helping manage potential side effects.
1. Semaglutide: Semaglutide activates GLP-1 receptors to improve glucose metabolism and digestive signaling. Administered weekly, it supports steady metabolic regulation and consistent, measurable progress over time.
Semaglutide is available in two FDA-approved formulations:
2. Tirzepatide: Tirzepatide targets both GLP-1 and GIP receptors, improving glucose regulation, insulin sensitivity, and fat metabolism. This dual-receptor mechanism produces more robust metabolic outcomes with a lower rate of gastrointestinal side effects, making it Dr. Larson’s preferred option for patients seeking significant, durable metabolic improvement.
Tirzepatide is available in two FDA-approved formulations:
Dr. Chad Larson uses a data-driven approach to select the medication that best aligns with your lab results, health needs, and treatment goals, with a focus on sustainable, long-term progress.
Our GLP-1 therapy services serve Del Mar patients whose weight resistance reflects metabolic dysfunction rather than lack of effort. This program supports patients whose physiology requires medical intervention to restore proper appetite regulation, glucose balance, and energy use.
When glucose processing is impaired, the body may be more likely to store excess energy as fat rather than use it efficiently. Dr. Chad Larson provides GLP-1 therapy for Del Mar patients to support insulin response, glucose regulation, and metabolic function. With appropriate testing and ongoing monitoring, treatment may also help improve blood sugar control and body composition while reducing certain metabolic risk factors.
Conditions such as polycystic ovary syndrome (PCOS), perimenopause, and thyroid imbalances can create additional challenges for weight management. Dr. Chad Larson may incorporate GLP-1 therapy for Del Mar patients to support appetite regulation and address metabolic factors associated with hormonal changes. When appropriate, he may also coordinate treatment with services such as bioidentical hormone therapy to provide more comprehensive support.
Many Del Mar patients seek care after diet-based programs have not produced lasting results. Dr. Chad Larson takes a medically guided approach that evaluates metabolic factors traditional strategies may overlook. His evidence-based care is designed to support steady, sustainable progress rather than repeated short-term cycles.
Choosing the right naturopathic doctor can shape your overall care experience. Dr. Chad Larson provides Del Mar patients with a personalized approach centered on clinical evaluation, physician oversight, and precision-guided treatment rather than automated or standardized protocols.
Ready to gain greater clarity about your metabolic health? Dr. Chad Larson bases each recommendation on a thorough clinical evaluation and ongoing oversight. His GLP-1 therapy for Del Mar patients is guided by how your body responds throughout treatment.
You will understand what is being addressed, why each intervention is recommended, and how your progress is measured over time. Contact Dr. Larson today to schedule a consultation and learn more about his medical weight loss programs and GLP-1 therapy options.
Most patients in Del Mar notice appetite changes and improved energy within the first 1–2 weeks of GLP-1 therapy. Significant body composition changes usually take several months as your metabolism stabilizes. We monitor your progress and adjust your treatment to keep you on track.
GLP-1 therapy is generally considered safe for appropriate patients when prescribed and monitored by a qualified medical provider, although side effects can occur. Dr. Chad Larson requires lab testing before treatment to determine whether it may be suitable for you. He also provides regular follow-up care to monitor your response, adjust treatment when needed, and address any concerns.
Yes. GLP-1 therapy works best when combined with balanced nutrition and regular physical activity. The medication supports metabolic regulation, but sustainable results still depend on consistent lifestyle habits over time.
Standard weight management programs often focus primarily on behavior without fully evaluating underlying biological factors. Dr. Chad Larson uses GLP-1 therapy to address systems involved in hunger, satiety, glucose regulation, and energy balance. He tailors each treatment plan to your lab results, health history, and individual response rather than relying on a standardized protocol.
We don’t require rigid meal plans, but we offer personalized recommendations to enhance your results. Our team suggests whole foods that stabilize blood sugar and provide steady energy, making it easy to incorporate Del Mar’s fresh, quality food options into your routine.
